Trial intelligence / Profile preview

Coriolus Versicolor in Unresectable Hepatocellular Carcinoma

NCT01097083Phase 2Terminated

Sponsor
National University Hospital
Start
Apr 2010
Primary completion
Oct 2013
Modality
Botanical drug, Nutraceutical, Polysaccharide
Countries
1
01

Overview

A Phase 2 trial of trametes versicolor in hepatocellular carcinoma (HCC), sponsored by National University Hospital. Started Apr 2010; status: terminated.

02

Drugs

trametes versicolor
03

Conditions

hepatocellular carcinoma (HCC)

Beyond the preview

Go deeper on NCT01097083.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01097083.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call